Wang P, Matton L, Kebir F, Kerrou K, et al. Pralsetinib and Sequential MET Inhibitors to Overcome MET Amplification Resistance in a Patient With a RET Fusion Driven Lung Cancer - Case Report. Clin Lung Cancer 2022 Aug 20. pii: S1525-7304(22)00191.
PMID: 36127251